A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.
|Articles|November 9, 2021
Daily OTC Pearl: Diurex Water Capsules
Author(s)Saro Arakelians, PharmD
Diurex Water Capsules treat bloating, swelling, and other signs of water weight gain related to menstrual symptoms.
Advertisement
OTC/Lifestyle Pearl of the Day: Diurex Water Capsules
Indication: Diurex Water Capsules is a diuretic (water pill).
Insight:
- Diurex works by increasing urination.
- Diurex Water Capsules is used to treat
bloating , swelling, feelings of fullness, and other signs of water weight gain related to menstrual symptoms. - Diurex Water Capsules may also be used for purposes not listed in this medication guide.
- Caution: Before taking this medication speak with the health care provider, especially if history of kidney disease or heart conditions
- Direction: For best results, begin taking Diurex Water Capsules 5 or 6 days before you expect your menstrual period to start. Keep using the medicine until you get relief from symptoms, or until your period ends.
- Do not take more than 4 doses of pamabrom in a 24-hour period.
- Drink 6 to 8 glasses of water each day while you are taking Diurex Water Capsules.
- Manufacturer: Alva-Amco Pharmacal Companies
Sources:
Advertisement
Related to this article
Phase 2b data from EASD 2026 show the amylin-incretin combination also cut HbA1c by up to 2.9% in adults with obesity or overweight and type 2 diabetes.
American Pharmacists Month kicked off on October 1, honoring more than 700,000 pharmacy professionals and 250 years of caring for America's communities.
fMRI data show cagrilintide-semaglutide altered brain responses to high-calorie food cues; REIMAGINE analyses point to ectopic fat and bone effects.
A pharmacist-led collaborative drug therapy management program at NYC Health + Hospitals/Bellevue reported high patient satisfaction, and every surveyed patient said they felt respected and supported by their pharmacist.
A Novo Nordisk–funded claims analysis of adults with type 2 diabetes found an adjusted HR of 1.06 for MACE with switching, although the findings cannot show causation.
Invasive pneumococcal disease may be the first sign of undiagnosed blood cancers and antibody deficiencies in adults, a new study finds.
A new analysis finds a significant weight loss edge for tirzepatide under one estimand but not another; no head-to-head trial exists at these doses.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Why Lp(a) Testing Lagged Behind LDL Cholesterol Screening
2
FDA Approves Pirtobrutinib for Previously Untreated CLL/SLL
3
Statin Myths: Why Patients Avoid Cholesterol-Lowering Therapy
4
EloraTZP Delivers Up to 23.3% Weight Loss in Adults With Obesity and T2D
5